Aboleris Pharma is a clinical-stage biopharmaceutical company committed to improving the lives of people suffering from autoimmune diseases and organ transplantation rejection
Aboleris Pharma is a clinical-stage biopharmaceutical company committed to improving the lives of people suffering from autoimmune diseases and organ transplantation rejection. We are developing potentially best-in-class and first-in-class, curative-intent therapies designed to restore immune tolerance by inducing an immune system reset.